25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0ME (Twist Bioscience Corp) Stock Analysis
Buy, Hold or Sell?

Let's analyze Twist Bioscience Corp together

I guess you are interested in Twist Bioscience Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Twist Bioscience Corp’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Twist Bioscience Corp’s Price Targets

I'm going to help you getting a better view of Twist Bioscience Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Twist Bioscience Corp

I send you an email if I find something interesting about Twist Bioscience Corp.

1. Quick Overview

1.1. Quick analysis of Twist Bioscience Corp (30 sec.)










1.2. What can you expect buying and holding a share of Twist Bioscience Corp? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€6.22
Expected worth in 1 year
€4.52
How sure are you?
26.1%

+ What do you gain per year?

Total Gains per Share
€-1.70
Return On Investment
-5.6%

For what price can you sell your share?

Current Price per Share
€30.39
Expected price per share
€19.93 - €40.29
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Twist Bioscience Corp (5 min.)




Live pricePrice per Share (EOD)
€30.39
Intrinsic Value Per Share
€24.42 - €30.20
Total Value Per Share
€30.64 - €36.42

2.2. Growth of Twist Bioscience Corp (5 min.)




Is Twist Bioscience Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$440m$607.7m-$142.8m-30.7%

How much money is Twist Bioscience Corp making?

Current yearPrevious yearGrowGrow %
Making money-$47.7m-$48m$247.4k0.5%
Net Profit Margin-56.0%-69.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Twist Bioscience Corp (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#44 / 131

Most Revenue
#49 / 131

Most Profit
#123 / 131
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Twist Bioscience Corp?

Welcome investor! Twist Bioscience Corp's management wants to use your money to grow the business. In return you get a share of Twist Bioscience Corp.

First you should know what it really means to hold a share of Twist Bioscience Corp. And how you can make/lose money.

Speculation

The Price per Share of Twist Bioscience Corp is €30.39. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Twist Bioscience Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Twist Bioscience Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €6.22. Based on the TTM, the Book Value Change Per Share is €-0.42 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Twist Bioscience Corp.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-0.66-2.2%-0.80-2.6%-0.80-2.6%-0.83-2.7%-0.76-2.5%-0.74-2.4%
Usd Book Value Change Per Share-0.26-0.9%-0.50-1.6%-0.60-2.0%-0.59-1.9%0.150.5%0.321.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.26-0.9%-0.50-1.6%-0.60-2.0%-0.59-1.9%0.150.5%0.321.1%
Usd Price Per Share42.59-47.79-30.08-36.08-58.71-54.31-
Price to Earnings Ratio-16.22--17.28--9.71--11.91--22.42--20.84-
Price-to-Total Gains Ratio-161.19--133.97--53.07--78.35--186.50--162.57-
Price to Book Ratio5.80-6.16-3.02-3.84-6.32-6.78-
Price-to-Total Gains Ratio-161.19--133.97--53.07--78.35--186.50--162.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share35.884512
Number of shares27
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.500.15
Usd Total Gains Per Share-0.500.15
Gains per Quarter (27 shares)-13.523.96
Gains per Year (27 shares)-54.0815.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-54-640166
20-108-11803222
30-162-17204838
40-216-22606354
50-270-28007970
60-324-33409586
70-379-3880111102
80-433-4420127118
90-487-4960143134
100-541-5500159150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.023.00.00.0%0.023.00.00.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%6.017.00.026.1%6.017.00.026.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%6.017.00.026.1%6.017.00.026.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Twist Bioscience Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.224-0.424+90%-0.508+127%-0.498+123%0.124-280%0.270-183%
Book Value Per Share--6.2206.571-5%8.590-28%8.658-28%8.458-26%7.674-19%
Current Ratio--4.5144.815-6%5.849-23%5.768-22%7.674-41%7.374-39%
Debt To Asset Ratio--0.2610.243+7%0.196+33%0.204+28%0.181+44%0.194+35%
Debt To Equity Ratio--0.3530.322+10%0.244+45%0.259+37%0.225+57%0.253+40%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--2029490399.4002298770267.200-12%1401047137.550+45%1701464763.183+19%2867460004.260-29%2651837287.600-23%
Eps---0.556-0.675+22%-0.679+22%-0.700+26%-0.640+15%-0.629+13%
Ev To Sales Ratio--6.4577.844-18%5.882+10%7.018-8%20.805-69%20.796-69%
Free Cash Flow Per Share---0.242-0.231-4%-0.338+39%-0.439+81%-0.494+104%-0.512+112%
Free Cash Flow To Equity Per Share---0.197-0.134-32%-0.337+71%-0.408+107%0.029-787%0.113-275%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--30.201----------
Intrinsic Value_10Y_min--24.424----------
Intrinsic Value_1Y_max---1.065----------
Intrinsic Value_1Y_min---1.049----------
Intrinsic Value_3Y_max---0.082----------
Intrinsic Value_3Y_min---0.142----------
Intrinsic Value_5Y_max--4.660----------
Intrinsic Value_5Y_min--4.057----------
Market Cap1820850279.000-19%2161173727.0002425104147.500-11%1526212857.250+42%1830786365.583+18%2978968575.900-27%2755567489.478-22%
Net Profit Margin---0.424-0.560+32%-0.699+65%-0.730+72%-0.890+110%-1.073+153%
Operating Margin----0%-0.1910%-0.3180%-0.6610%-0.8600%
Operating Ratio--1.9521.985-2%2.310-16%2.303-15%2.508-22%2.655-26%
Pb Ratio4.886-19%5.7996.158-6%3.020+92%3.840+51%6.319-8%6.781-14%
Pe Ratio-13.669+16%-16.224-17.281+7%-9.709-40%-11.915-27%-22.424+38%-20.836+28%
Price Per Share30.390-19%36.07040.475-11%25.473+42%30.556+18%49.719-27%45.990-22%
Price To Free Cash Flow Ratio-31.382+16%-37.247-53.821+44%-19.476-48%-28.896-22%-33.127-11%-29.082-22%
Price To Total Gains Ratio-135.810+16%-161.193-133.972-17%-53.068-67%-78.347-51%-186.497+16%-162.574+1%
Quick Ratio--1.2891.219+6%1.263+2%1.453-11%2.257-43%2.264-43%
Return On Assets---0.066-0.077+17%-0.063-4%-0.066+0%-0.063-5%-0.079+19%
Return On Equity---0.089-0.102+14%-0.079-12%-0.083-7%-0.077-13%-0.105+17%
Total Gains Per Share---0.224-0.424+90%-0.508+127%-0.498+123%0.124-280%0.270-183%
Usd Book Value--440064622.956464923422.631-5%607728846.341-28%612552204.237-28%598416014.304-26%542940612.933-19%
Usd Book Value Change Per Share---0.264-0.501+90%-0.600+127%-0.589+123%0.147-280%0.319-183%
Usd Book Value Per Share--7.3457.760-5%10.143-28%10.223-28%9.988-26%9.062-19%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--2396422263.6122714387931.510-12%1654356460.019+45%2009089592.367+19%3385896773.030-29%3131289469.198-23%
Usd Eps---0.656-0.797+22%-0.802+22%-0.826+26%-0.755+15%-0.743+13%
Usd Free Cash Flow---17128311.667-16371136.302-4%-23878396.313+39%-31059021.854+81%-34973502.672+104%-33081391.351+93%
Usd Free Cash Flow Per Share---0.286-0.273-4%-0.399+39%-0.518+81%-0.584+104%-0.605+112%
Usd Free Cash Flow To Equity Per Share---0.233-0.158-32%-0.398+71%-0.481+107%0.034-787%0.133-275%
Usd Market Cap2150060009.443-19%2551913936.8422863562977.368-11%1802152141.841+42%2161792540.481+18%3517566094.423-27%3253774091.576-22%
Usd Price Per Share35.885-19%42.59147.793-11%30.078+42%36.080+18%58.708-27%54.306-22%
Usd Profit---39324123.832-47782290.113+22%-48029765.720+22%-49653272.358+26%-45333031.536+15%-44575475.773+13%
Usd Revenue--92783854.32286911433.165+7%69364662.745+34%71076993.961+31%56450735.667+64%51356850.813+81%
Usd Total Gains Per Share---0.264-0.501+90%-0.600+127%-0.589+123%0.147-280%0.319-183%
 EOD+3 -5MRQTTM+15 -20YOY+24 -113Y+23 -125Y+13 -2210Y+15 -20

3.3 Fundamental Score

Let's check the fundamental score of Twist Bioscience Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.669
Price to Book Ratio (EOD)Between0-14.886
Net Profit Margin (MRQ)Greater than0-0.424
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.289
Current Ratio (MRQ)Greater than14.514
Debt to Asset Ratio (MRQ)Less than10.261
Debt to Equity Ratio (MRQ)Less than10.353
Return on Equity (MRQ)Greater than0.15-0.089
Return on Assets (MRQ)Greater than0.05-0.066
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Twist Bioscience Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.025
Ma 20Greater thanMa 5029.119
Ma 50Greater thanMa 10028.622
Ma 100Greater thanMa 20033.202
OpenGreater thanClose30.290
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2025-06-25 21:05:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Twist Bioscience Corp earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -42.4%Β means thatΒ €-0.42 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Twist Bioscience Corp:

  • The MRQ is -42.4%. The company is making a huge loss. -2
  • The TTM is -56.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-42.4%TTM-56.0%+13.6%
TTM-56.0%YOY-69.9%+13.9%
TTM-56.0%5Y-89.0%+33.0%
5Y-89.0%10Y-107.3%+18.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.4%-5.0%-37.4%
TTM-56.0%-6.6%-49.4%
YOY-69.9%-8.0%-61.9%
3Y-73.0%-8.5%-64.5%
5Y-89.0%-3.2%-85.8%
10Y-107.3%-1.0%-106.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Twist Bioscience Corp is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • -6.6% Return on Assets means thatΒ Twist Bioscience Corp generatedΒ €-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Twist Bioscience Corp:

  • The MRQ is -6.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-7.7%+1.1%
TTM-7.7%YOY-6.3%-1.4%
TTM-7.7%5Y-6.3%-1.4%
5Y-6.3%10Y-7.9%+1.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.6%-0.7%-5.9%
TTM-7.7%-1.0%-6.7%
YOY-6.3%-1.1%-5.2%
3Y-6.6%-1.1%-5.5%
5Y-6.3%--6.3%
10Y-7.9%0.3%-8.2%
4.3.1.3. Return on Equity

Shows how efficient Twist Bioscience Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • -8.9% Return on Equity means Twist Bioscience Corp generated €-0.09Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Twist Bioscience Corp:

  • The MRQ is -8.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-10.2%+1.2%
TTM-10.2%YOY-7.9%-2.3%
TTM-10.2%5Y-7.7%-2.4%
5Y-7.7%10Y-10.5%+2.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.9%-0.7%-8.2%
TTM-10.2%-0.8%-9.4%
YOY-7.9%-1.1%-6.8%
3Y-8.3%-1.4%-6.9%
5Y-7.7%-1.0%-6.7%
10Y-10.5%-1.0%-9.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Twist Bioscience Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Twist Bioscience Corp is operatingΒ .

  • Measures how much profit Twist Bioscience Corp makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Twist Bioscience Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-19.1%+19.1%
TTM-5Y-66.1%+66.1%
5Y-66.1%10Y-86.0%+19.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.0%+2.0%
TTM--10.7%+10.7%
YOY-19.1%-5.5%-13.6%
3Y-31.8%-0.1%-31.7%
5Y-66.1%4.0%-70.1%
10Y-86.0%4.5%-90.5%
4.3.2.2. Operating Ratio

Measures how efficient Twist Bioscience Corp is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 1.95 means that the operating costs are €1.95 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Twist Bioscience Corp:

  • The MRQ is 1.952. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.985. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.952TTM1.985-0.033
TTM1.985YOY2.310-0.325
TTM1.9855Y2.508-0.523
5Y2.50810Y2.655-0.147
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9521.375+0.577
TTM1.9851.295+0.690
YOY2.3101.292+1.018
3Y2.3031.284+1.019
5Y2.5081.259+1.249
10Y2.6551.189+1.466
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Twist Bioscience Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Twist Bioscience Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 4.51Β means the company has €4.51 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Twist Bioscience Corp:

  • The MRQ is 4.514. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.815. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.514TTM4.815-0.301
TTM4.815YOY5.849-1.034
TTM4.8155Y7.674-2.858
5Y7.67410Y7.374+0.300
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5142.072+2.442
TTM4.8152.087+2.728
YOY5.8492.424+3.425
3Y5.7682.472+3.296
5Y7.6742.618+5.056
10Y7.3743.175+4.199
4.4.3.2. Quick Ratio

Measures if Twist Bioscience Corp is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 1.29Β means the company can pay off €1.29 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Twist Bioscience Corp:

  • The MRQ is 1.289. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.219. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.289TTM1.219+0.070
TTM1.219YOY1.263-0.044
TTM1.2195Y2.257-1.038
5Y2.25710Y2.264-0.007
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2891.085+0.204
TTM1.2191.146+0.073
YOY1.2631.371-0.108
3Y1.4531.598-0.145
5Y2.2571.843+0.414
10Y2.2642.228+0.036
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Twist Bioscience Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Twist Bioscience CorpΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Twist Bioscience Corp to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.26Β means that Twist Bioscience Corp assets areΒ financed with 26.1% credit (debt) and the remaining percentage (100% - 26.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Twist Bioscience Corp:

  • The MRQ is 0.261. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.243. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.261TTM0.243+0.018
TTM0.243YOY0.196+0.047
TTM0.2435Y0.181+0.062
5Y0.18110Y0.194-0.013
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2610.385-0.124
TTM0.2430.426-0.183
YOY0.1960.385-0.189
3Y0.2040.387-0.183
5Y0.1810.407-0.226
10Y0.1940.446-0.252
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Twist Bioscience Corp is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 35.3% means that company has €0.35 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Twist Bioscience Corp:

  • The MRQ is 0.353. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.322. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.353TTM0.322+0.032
TTM0.322YOY0.244+0.078
TTM0.3225Y0.225+0.097
5Y0.22510Y0.253-0.028
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3530.592-0.239
TTM0.3220.582-0.260
YOY0.2440.568-0.324
3Y0.2590.677-0.418
5Y0.2250.667-0.442
10Y0.2530.643-0.390
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Twist Bioscience Corp generates.

  • Above 15 is considered overpriced butΒ always compareΒ Twist Bioscience Corp to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -16.22 means the investor is paying €-16.22Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Twist Bioscience Corp:

  • The EOD is -13.669. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.224. Based on the earnings, the company is expensive. -2
  • The TTM is -17.281. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.669MRQ-16.224+2.555
MRQ-16.224TTM-17.281+1.057
TTM-17.281YOY-9.709-7.572
TTM-17.2815Y-22.424+5.143
5Y-22.42410Y-20.836-1.588
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-13.669-0.515-13.154
MRQ-16.224-0.756-15.468
TTM-17.281-0.557-16.724
YOY-9.709-0.132-9.577
3Y-11.915-0.087-11.828
5Y-22.4245.675-28.099
10Y-20.8367.829-28.665
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Twist Bioscience Corp:

  • The EOD is -31.382. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -37.247. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -53.821. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-31.382MRQ-37.247+5.865
MRQ-37.247TTM-53.821+16.574
TTM-53.821YOY-19.476-34.345
TTM-53.8215Y-33.127-20.694
5Y-33.12710Y-29.082-4.045
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-31.382-0.766-30.616
MRQ-37.247-1.081-36.166
TTM-53.821-0.557-53.264
YOY-19.476-1.055-18.421
3Y-28.896-0.440-28.456
5Y-33.127-0.670-32.457
10Y-29.082-0.902-28.180
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Twist Bioscience Corp is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 5.80 means the investor is paying €5.80Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Twist Bioscience Corp:

  • The EOD is 4.886. Based on the equity, the company is fair priced.
  • The MRQ is 5.799. Based on the equity, the company is overpriced. -1
  • The TTM is 6.158. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.886MRQ5.799-0.913
MRQ5.799TTM6.158-0.359
TTM6.158YOY3.020+3.139
TTM6.1585Y6.319-0.161
5Y6.31910Y6.781-0.462
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD4.8861.943+2.943
MRQ5.7992.034+3.765
TTM6.1582.143+4.015
YOY3.0202.305+0.715
3Y3.8402.491+1.349
5Y6.3193.521+2.798
10Y6.7814.485+2.296
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets595,615
Total Liabilities155,507
Total Stockholder Equity440,108
 As reported
Total Liabilities 155,507
Total Stockholder Equity+ 440,108
Total Assets = 595,615

Assets

Total Assets595,615
Total Current Assets338,442
Long-term Assets257,173
Total Current Assets
Cash And Cash Equivalents 210,437
Short-term Investments 46,710
Net Receivables 49,949
Inventory 20,860
Other Current Assets 10,486
Total Current Assets  (as reported)338,442
Total Current Assets  (calculated)338,442
+/-0
Long-term Assets
Property Plant Equipment 151,208
Goodwill 85,811
Intangible Assets 13,951
Long-term Assets Other 6,203
Long-term Assets  (as reported)257,173
Long-term Assets  (calculated)257,173
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities74,976
Long-term Liabilities80,531
Total Stockholder Equity440,108
Total Current Liabilities
Accounts payable 8,063
Other Current Liabilities 455
Total Current Liabilities  (as reported)74,976
Total Current Liabilities  (calculated)8,518
+/- 66,458
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt80,298
Long-term Liabilities  (as reported)80,531
Long-term Liabilities  (calculated)80,298
+/- 233
Total Stockholder Equity
Total Stockholder Equity (as reported)440,108
Total Stockholder Equity (calculated)0
+/- 440,108
Other
Common Stock Shares Outstanding 59,857
Net Invested Capital 440,108
Net Working Capital 263,466
Property Plant and Equipment Gross 238,702



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
186,994
192,277
323,872
408,240
398,882
699,570
677,289
725,298
702,097
786,167
1,021,636
979,663
961,378
909,970
853,924
810,332
776,403
732,815
702,846
638,118
614,323
608,580
595,615
595,615608,580614,323638,118702,846732,815776,403810,332853,924909,970961,378979,6631,021,636786,167702,097725,298677,289699,570398,882408,240323,872192,277186,994
   > Total Current Assets 
160,135
129,288
260,205
344,578
334,870
634,428
607,999
576,607
546,495
385,007
664,375
624,117
596,483
541,859
489,271
445,537
424,256
390,231
371,869
361,831
346,776
345,309
338,442
338,442345,309346,776361,831371,869390,231424,256445,537489,271541,859596,483624,117664,375385,007546,495576,607607,999634,428334,870344,578260,205129,288160,135
       Cash And Cash Equivalents 
46,735
26,032
184,395
207,853
93,667
348,789
399,329
475,279
465,829
191,624
407,627
376,249
378,687
316,681
315,196
307,459
286,470
266,269
243,348
239,142
226,316
221,403
210,437
210,437221,403226,316239,142243,348266,269286,470307,459315,196316,681378,687376,249407,627191,624465,829475,279399,329348,78993,667207,853184,39526,03246,735
       Short-term Investments 
91,372
77,075
45,669
103,906
196,335
238,496
156,329
44,129
12,034
110,235
166,231
151,342
126,281
122,029
72,462
49,686
49,943
44,875
49,994
50,276
50,083
49,424
46,710
46,71049,42450,08350,27649,99444,87549,94349,68672,462122,029126,281151,342166,231110,23512,03444,129156,329238,496196,335103,90645,66977,07591,372
       Net Receivables 
11,085
13,054
14,831
13,347
26,376
25,492
27,290
28,116
28,549
32,872
34,877
41,195
40,294
44,437
43,202
42,580
44,064
35,354
35,993
31,988
34,903
39,315
49,949
49,94939,31534,90331,98835,99335,35444,06442,58043,20244,43740,29441,19534,87732,87228,54928,11627,29025,49226,37613,34714,83113,05411,085
       Inventory 
7,330
7,416
10,764
13,161
12,289
13,409
15,838
21,224
31,800
40,239
44,591
43,022
39,307
44,597
39,923
36,354
32,063
30,863
30,376
28,484
24,078
23,518
20,860
20,86023,51824,07828,48430,37630,86332,06336,35439,92344,59739,30743,02244,59140,23931,80021,22415,83813,40912,28913,16110,7647,4167,330
       Other Current Assets 
84
0
83
84
0
0
0
0
0
0
0
12,309
11,914
14,115
13,503
9,458
11,716
12,870
12,158
11,941
11,396
11,649
10,486
10,48611,64911,39611,94112,15812,87011,7169,45813,50314,11511,91412,30900000008483084
   > Long-term Assets 
26,859
62,989
63,667
63,662
64,012
65,142
69,290
148,691
155,602
401,160
357,261
355,546
364,895
368,111
364,653
364,795
352,147
342,584
330,977
276,287
267,547
263,271
257,173
257,173263,271267,547276,287330,977342,584352,147364,795364,653368,111364,895355,546357,261401,160155,602148,69169,29065,14264,01263,66263,66762,98926,859
       Property Plant Equipment 
20,835
58,577
59,119
58,934
59,165
59,483
62,972
100,667
105,702
137,155
170,029
203,176
214,389
218,607
217,208
212,806
203,361
195,318
185,005
167,616
161,349
157,144
151,208
151,208157,144161,349167,616185,005195,318203,361212,806217,208218,607214,389203,176170,029137,155105,702100,66762,97259,48359,16558,93459,11958,57720,835
       Goodwill 
1,138
1,138
1,138
1,138
1,138
1,138
1,138
22,676
22,434
84,244
85,678
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,81185,81185,81185,81185,81185,81185,81185,81185,81185,81185,81185,81185,67884,24422,43422,6761,1381,1381,1381,1381,1381,1381,138
       Long Term Investments 
0
0
0
0
0
0
0
0
0
106,843
30,587
0
0
0
0
0
0
0
0
0
0
0
0
00000000000030,587106,843000000000
       Intangible Assets 
508
458
407
356
307
256
203
18,562
18,262
63,921
62,493
61,115
59,738
58,361
57,068
55,775
54,483
53,190
51,898
14,741
14,478
14,215
13,951
13,95114,21514,47814,74151,89853,19054,48355,77557,06858,36159,73861,11562,49363,92118,26218,562203256307356407458508
       Other Assets 
4,378
2,816
3,003
3,234
3,402
4,265
4,977
6,786
9,204
8,997
8,474
5,444
4,957
5,332
0
10,403
0
0
0
0
0
0
0
000000010,40305,3324,9575,4448,4748,9979,2046,7864,9774,2653,4023,2343,0032,8164,378
> Total Liabilities 
34,912
89,196
59,670
59,294
62,620
61,618
63,108
114,850
121,276
159,989
158,275
158,986
171,993
163,645
149,992
152,782
152,971
142,773
142,715
146,979
141,634
152,639
155,507
155,507152,639141,634146,979142,715142,773152,971152,782149,992163,645171,993158,986158,275159,989121,276114,85063,10861,61862,62059,29459,67089,19634,912
   > Total Current Liabilities 
30,354
57,844
30,210
31,377
36,029
37,102
40,442
54,833
63,052
80,034
84,632
92,686
90,663
83,837
72,108
72,822
73,323
65,228
67,490
73,757
71,006
69,646
74,976
74,97669,64671,00673,75767,49065,22873,32372,82272,10883,83790,66392,68684,63280,03463,05254,83340,44237,10236,02931,37730,21057,84430,354
       Short Long Term Debt 
3,333
3,333
3,333
3,333
3,333
3,333
3,168
7,545
1,552
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,5527,5453,1683,3333,3333,3333,3333,3333,333
       Accounts payable 
9,760
9,106
6,932
5,973
4,830
8,932
8,528
11,268
14,900
23,073
16,815
21,014
20,092
20,113
13,236
12,184
14,052
9,256
7,703
6,626
1,630
7,503
8,063
8,0637,5031,6306,6267,7039,25614,05212,18413,23620,11320,09221,01416,81523,07314,90011,2688,5288,9324,8305,9736,9329,1069,760
       Other Current Liabilities 
817
23,499
52
1,373
2,611
3,306
4,063
9,265
9,623
13,856
16,023
20,123
19,737
15,822
2,903
9,911
430
577
792
796
961
594
455
4555949617967925774309,9112,90315,82219,73720,12316,02313,8569,6239,2654,0633,3062,6111,3735223,499817
   > Long-term Liabilities 
4,558
31,352
29,460
27,917
26,591
24,516
22,666
60,017
58,224
79,955
73,643
66,300
81,330
79,808
77,884
79,960
79,648
77,545
75,225
73,222
70,628
82,993
80,531
80,53182,99370,62873,22275,22577,54579,64879,96077,88479,80881,33066,30073,64379,95558,22460,01722,66624,51626,59127,91729,46031,3524,558
       Long term Debt 
4,400
3,669
2,925
2,170
1,403
625
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000006251,4032,1702,9253,6694,400
       Capital Lease Obligations Min Short Term Debt
0
35,910
34,217
32,416
31,246
30,125
28,758
56,214
61,369
72,969
79,662
78,596
94,912
93,975
91,220
93,032
94,069
91,878
89,425
87,180
85,026
82,616
80,298
80,29882,61685,02687,18089,42591,87894,06993,03291,22093,97594,91278,59679,66272,96961,36956,21428,75830,12531,24632,41634,21735,9100
       Other Liabilities 
158
144
95
0
351
210
422
6,168
5,068
19,670
8,147
2,056
60
60
0
60
0
0
0
0
0
0
0
000000060060602,0568,14719,6705,0686,168422210351095144158
       Long-term Liabilities Other 
158
144
95
0
351
210
422
6,168
5,068
19,670
8,147
2,056
60
60
60
60
475
475
421
597
407
15,407
15,451
15,45115,407407597421475475606060602,0568,14719,6705,0686,168422210351095144158
> Total Stockholder Equity
152,082
103,081
264,202
348,946
336,262
637,952
614,181
610,448
580,821
626,178
863,361
820,677
789,385
746,325
703,932
657,550
623,432
590,042
560,131
491,139
472,689
455,941
440,108
440,108455,941472,689491,139560,131590,042623,432657,550703,932746,325789,385820,677863,361626,178580,821610,448614,181637,952336,262348,946264,202103,081152,082
   Common Stock
152,082
0
0
0
336,262
637,952
614,181
610,448
580,821
626,178
0
820,677
789,385
0
0
0
0
0
0
0
0
0
0
0000000000789,385820,6770626,178580,821610,448614,181637,952336,262000152,082
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
181
190
213
134
87
142
190
428
546
363
-475
-1,377
-1,843
-609
0
-635
0
0
0
0
0
0
0
0000000-6350-609-1,843-1,377-47536354642819014287134213190181



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue312,974
Cost of Revenue-179,625
Gross Profit133,349133,349
 
Operating Income (+$)
Gross Profit133,349
Operating Expense-488,875
Operating Income-175,901-355,526
 
Operating Expense (+$)
Research Development90,852
Selling General Administrative218,398
Selling And Marketing Expenses-
Operating Expense488,875309,250
 
Net Interest Income (+$)
Interest Income15,344
Interest Expense-29
Other Finance Cost-0
Net Interest Income15,315
 
Pretax Income (+$)
Operating Income-175,901
Net Interest Income15,315
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-208,166-128,321
EBIT - interestExpense = -29
-208,726
-208,697
Interest Expense29
Earnings Before Interest and Taxes (EBIT)--208,137
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-208,166
Tax Provision-560
Net Income From Continuing Ops-208,726-208,726
Net Income-208,726
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-47,580-15,315
 

Technical Analysis of Twist Bioscience Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Twist Bioscience Corp. The general trend of Twist Bioscience Corp is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Twist Bioscience Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Twist Bioscience Corp Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Twist Bioscience Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 31.42 < 34.42 < 40.29.

The bearish price targets are: 23.99 > 23.46 > 19.93.

Know someone who trades $0ME? Share this with them.πŸ‘‡

Twist Bioscience Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Twist Bioscience Corp. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Twist Bioscience Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Twist Bioscience Corp. The current macd is 0.70385166.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Twist Bioscience Corp price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Twist Bioscience Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Twist Bioscience Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Twist Bioscience Corp Daily Moving Average Convergence/Divergence (MACD) ChartTwist Bioscience Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Twist Bioscience Corp. The current adx is 22.96.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Twist Bioscience Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Twist Bioscience Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Twist Bioscience Corp. The current sar is 29.47.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Twist Bioscience Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Twist Bioscience Corp. The current rsi is 56.03. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Twist Bioscience Corp Daily Relative Strength Index (RSI) ChartTwist Bioscience Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Twist Bioscience Corp. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Twist Bioscience Corp price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Twist Bioscience Corp Daily Stochastic Oscillator ChartTwist Bioscience Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Twist Bioscience Corp. The current cci is 71.22.

Twist Bioscience Corp Daily Commodity Channel Index (CCI) ChartTwist Bioscience Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Twist Bioscience Corp. The current cmo is 14.96.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Twist Bioscience Corp Daily Chande Momentum Oscillator (CMO) ChartTwist Bioscience Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Twist Bioscience Corp. The current willr is -31.79012346.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Twist Bioscience Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Twist Bioscience Corp Daily Williams %R ChartTwist Bioscience Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Twist Bioscience Corp.

Twist Bioscience Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Twist Bioscience Corp. The current atr is 0.92732706.

Twist Bioscience Corp Daily Average True Range (ATR) ChartTwist Bioscience Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Twist Bioscience Corp. The current obv is 11,880.

Twist Bioscience Corp Daily On-Balance Volume (OBV) ChartTwist Bioscience Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Twist Bioscience Corp. The current mfi is 32.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Twist Bioscience Corp Daily Money Flow Index (MFI) ChartTwist Bioscience Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Twist Bioscience Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-19 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-04 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-24 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-28 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-21 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-22 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-05 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-09 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-18 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Twist Bioscience Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Twist Bioscience Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.025
Ma 20Greater thanMa 5029.119
Ma 50Greater thanMa 10028.622
Ma 100Greater thanMa 20033.202
OpenGreater thanClose30.290
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Twist Bioscience Corp with someone you think should read this too:
  • Are you bullish or bearish on Twist Bioscience Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Twist Bioscience Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Twist Bioscience Corp

I send you an email if I find something interesting about Twist Bioscience Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Twist Bioscience Corp.

Receive notifications about Twist Bioscience Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.